According to filings with the U.S. Securities and Exchange Commission, Lucem Health is raising up to $8,397,541.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Lucem Health
Lucem Health helps healthcare systems identify patients earlier and guide them into the care they need. Using existing EHR data, we power proactive care delivery programs that identify patients who could benefit from further evaluation and guide them into appropriate care using existing workflows. This enables earlier intervention, better use of specialty capacity, and improved outcomes across the system. When the right patients reach care sooner, health systems perform better – clinically and operationally – without adding burden to clinicians or staff.

To learn more about Lucem Health, visit https://lucemhealth.com/
Lucem Health Linkedin Page: https://www.linkedin.com/company/lucem-health/

Contact:
Sean Cassidy, Chief Executive Officer
919-371-6323
https://www.linkedin.com/in/sean-cassidy-5b6791/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.